Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-03-01 @ 10:06 AM
Study NCT ID:
NCT00612534
Status:
COMPLETED
Last Update Posted:
2014-02-17
First Post:
2008-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee Replacement
Sponsor:
Talphera, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03
Start Date Type:
None
Primary Completion Date:
2008-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-28
First Submit QC Date:
None
Study First Post Date:
2008-02-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-10-18
Results First Submit QC Date:
None
Results First Post Date:
2014-02-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-22
Last Update Post Date:
2014-02-17
Last Update Post Date Type:
ESTIMATED